D Bennabi1, M Nicolier2, J Monnin2, G Tio3, L Pazart4, P Vandel2, E Haffen2. 1. Department of Clinical Psychiatry, University Hospital of Besançon, France; EA 481 Neurosciences, University of Franche-Comté, France. Electronic address: dbennabi@chu-besancon.fr. 2. Department of Clinical Psychiatry, University Hospital of Besançon, France; CIC-IT 1431, INSERM, University Hospital of Besançon, France; EA 481 Neurosciences, University of Franche-Comté, France. 3. Department of Clinical Psychiatry, University Hospital of Besançon, France; CIC-IT 1431, INSERM, University Hospital of Besançon, France. 4. CIC-IT 1431, INSERM, University Hospital of Besançon, France.
Abstract
OBJECTIVE: This double-blind, sham-controlled trial investigated the effects of two daily tDCS sessions over a 5-day period in treatment-resistant depression. METHOD: Twenty-four treatment-resistant depressed patients receivedtwo daily sessions of active or sham anodal tDCS to the left prefrontal cortex (2 mA, 10 sessions over 1 week). Depression severity, psychomotor retardation and cognitive function were assessed. RESULTS: Active tDCS was not significantly superior to sham tDCS on the HDRS at week 4, as well as on the MADRS and SRRS scales, and on neuropsychological tests. Response rates were not significantly higher with active tDCS. tDCS was well tolerated, with mild adverse events limited to transient scalp discomfort. CONCLUSION:tDCS did not induce clinically relevant antidepressant effect in active and sham stimulation groups. There was no impact on psychomotor and neuropsychological functioning. SIGNIFICANCE: tDCS efficacy on specific symptom profiles in pharmacotherapy-resistant depression is limited. The use of optimized stimulation protocol and longer period of follow up may valuably contribute to specify the place of tDCS in treatment-resistant depression.
RCT Entities:
OBJECTIVE: This double-blind, sham-controlled trial investigated the effects of two daily tDCS sessions over a 5-day period in treatment-resistant depression. METHOD: Twenty-four treatment-resistant depressedpatients received two daily sessions of active or sham anodal tDCS to the left prefrontal cortex (2 mA, 10 sessions over 1 week). Depression severity, psychomotor retardation and cognitive function were assessed. RESULTS: Active tDCS was not significantly superior to sham tDCS on the HDRS at week 4, as well as on the MADRS and SRRS scales, and on neuropsychological tests. Response rates were not significantly higher with active tDCS. tDCS was well tolerated, with mild adverse events limited to transient scalp discomfort. CONCLUSION: tDCS did not induce clinically relevant antidepressant effect in active and sham stimulation groups. There was no impact on psychomotor and neuropsychological functioning. SIGNIFICANCE: tDCS efficacy on specific symptom profiles in pharmacotherapy-resistant depression is limited. The use of optimized stimulation protocol and longer period of follow up may valuably contribute to specify the place of tDCS in treatment-resistant depression.
Authors: André R Brunoni; Adriano H Moffa; Felipe Fregni; Ulrich Palm; Frank Padberg; Daniel M Blumberger; Zafiris J Daskalakis; Djamila Bennabi; Emmanuel Haffen; Angelo Alonzo; Colleen K Loo Journal: Br J Psychiatry Date: 2016-04-07 Impact factor: 9.319
Authors: A Antal; I Alekseichuk; M Bikson; J Brockmöller; A R Brunoni; R Chen; L G Cohen; G Dowthwaite; J Ellrich; A Flöel; F Fregni; M S George; R Hamilton; J Haueisen; C S Herrmann; F C Hummel; J P Lefaucheur; D Liebetanz; C K Loo; C D McCaig; C Miniussi; P C Miranda; V Moliadze; M A Nitsche; R Nowak; F Padberg; A Pascual-Leone; W Poppendieck; A Priori; S Rossi; P M Rossini; J Rothwell; M A Rueger; G Ruffini; K Schellhorn; H R Siebner; Y Ugawa; A Wexler; U Ziemann; M Hallett; W Paulus Journal: Clin Neurophysiol Date: 2017-06-19 Impact factor: 3.708
Authors: Noah S Philip; Brent G Nelson; Flavio Frohlich; Kelvin O Lim; Alik S Widge; Linda L Carpenter Journal: Am J Psychiatry Date: 2017-02-24 Impact factor: 18.112
Authors: Simon Newstead; Hayley Young; David Benton; Gabriela Jiga-Boy; Maria L Andrade Sienz; R M Clement; Frédéric Boy Journal: Exp Brain Res Date: 2017-11-02 Impact factor: 1.972